Zacks Research issued their FY2027 earnings estimates for shares of Charles River Laboratories International in a report ...

Proficio Capital Partners LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – ...

Charles River Laboratories International Inc. closed 39.25% below its 52-week high of $274.77, which the company reached on ...

Japanese drugmaker Seikagaku Corporation (TYO: 4548) announced that it has received a complete response letter (CRL) from the ...

Charles River Laboratories International Inc. closed 37.75% short of its 52-week high of $274.77, which the company reached on March 22nd.

Bell Asset Management, an investment management company, released its Q4 2024 “Bell Global Equities Fund” investor letter. A ...

Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings tomorrow before the bell. Here’s what investors should know. Charles River Laboratories beat analysts’ revenue ...

Charles River Laboratories International, Inc. CRL reported fourth-quarter 2024 adjusted earnings per share (EPS) of $2.66, which rose 8.1% year over year. The figure surpassed the Zacks Consensus ...

Redburn Atlantic upgraded Charles River (CRL) to Neutral from Sell with an $188 price target The firm says demand in the company’s Discovery ...

Lab services company Charles River Laboratories (NYSE:CRL) reported Q4 CY2024 results exceeding the market’s revenue expectations , but sales fell by 1.1% year on year to $1.00 billion.

Citi analyst Patrick Donnelly upgraded Charles River (CRL) to Neutral from Sell with a price target of $175, up from $155. The firm thinks ...